Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report.

IF 2.3 Q1 OTORHINOLARYNGOLOGY

Allergy & Rhinology Pub Date : 2022-01-10 eCollection Date: 2022-01-01 DOI:10.1177/21526567211068458

Stephanie G Brooks, Anna M De Jong, Mina Abbaslou, Gordon Sussman

引用次数: 12

Abstract

New adverse reactions to the COVID-19 vaccines are being identified as vaccination rates increase worldwide. Recently, there have been two reports of Moderna (mRNA-1273) vaccine induced relapse of chronic spontaneous urticaria (CSU) that was previously well controlled. Herein, we report a case of AstraZeneca/Oxford (ChAdOx1) vaccine triggered CSU in a patient with no history of CSU with achieved remission.

查看原文本刊更多论文

阿斯利康/牛津COVID-19疫苗引发的慢性自发性荨麻疹获得缓解:一例报告

随着全球疫苗接种率的上升，正在发现新的COVID-19疫苗不良反应。最近，有两篇关于Moderna (mRNA-1273)疫苗诱导慢性自发性荨麻疹(CSU)复发的报道，而这些疾病以前得到了很好的控制。在此，我们报告了一例阿斯利康/牛津(ChAdOx1)疫苗引发的CSU患者，该患者无CSU病史，但已获得缓解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergy & Rhinology OTORHINOLARYNGOLOGY-

CiteScore

3.30

自引率

4.50%

发文量

审稿时长

15 weeks